Center for Biologics Evaluation and Research (CBER), Biologics Effectiveness and Safety (BEST) Initiative #3: Data Sources for Surveillance of Biologics
Award Notice Posted
- Solicitation number
- 75F40124R00002-CVS
- Agency
-
FDA Office of Acquisition and Grant Services
Food and Drug Administration, Department of Health and Human Services
- Awarded
- to CVS Healthspire Payor & Life Sciences LLC
- Set-aside
- No set-aside
Opportunity facts
- Contract number
- 75F40124D00042 Federal IDV award
- NAICS code
- 518210 Computing Infrastructure Providers, Data Processing, Web Hosting, and Related Services
- Place of performance
- United States
- Points of contact
Notice details come from SAM.gov. Updated .
About this opportunity
The Department of Health and Human Services Food and Drug Administration Office of Acquisition and Grant Services awarded a multiple award Indefinite Delivery/Indefinite Quantity (ID/IQ) contract for the Center for Biologics Evaluation and Research (CBER)'s Biologics Effectiveness and Safety (BEST) Initiative #3: Health Care Data Sources for Surveillance of Biologics. The contract has a $75,000,000.00 IDIQ ceiling for each contract and was awarded to CVS HEALTH CLINICAL TRIAL SERVICES LLC on September 27, 2024.
Notice text
Multiple Award Indefinite Delivery / Indefinite Quantity (ID/IQ) contract for the Food and Drug Administration (FDA), Center for Biologics Evaluation and Research (CBER), Biologics Effectiveness and Safety (BEST) Initiative #3: Health Care Data Sources for Surveillance of Biologics (BEST 3).
$75,000,000.00 IDIQ ceiling for each contract.
Awarded contract 75F40124D00042 to CVS HEALTH CLINICAL TRIAL SERVICES LLC for 75000000.00 on 2024-09-27.
Notice history
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity